Also known as آسٹیوپوروسس مینجمنٹ
General Physician
M.B.B.S., MRCGP (UK)
Diabetologist
M.B.B.S., Dip. in Diabetes, FD-CFMP
Nephrologist
MBBS, FCPS (Nephrology)
Gastroenterologist
MBBS, FCPS (Gastroenterology)
Neurologist
MBBS, Diploma in Diabetology, MCPS
Internal Medicine Specialist
MBBS, FCPS (Medicine)
Diabetologist
M.B.B.S, RMP, (KHI), Diabetes Trained Physician (DTP-CERTIFICATION), Smoking Cessation Specialist - Tobacco Cessation Control Center
Diabetologist
M.B.B.S, RMP, (KHI), Diabetes Trained Physician (DTP-CERTIFICATION), Smoking Cessation Specialist - Tobacco Cessation Control Center
Internal Medicine Specialist
M.B.B.S, M.D (USA), M.C.P.S, M.R.C.G.P
Internal Medicine Specialist
MD(Neurology), F.C.P.S. (Medicine), MRCP (UK), FRCP LONDON
Internal Medicine Specialist
MD(Neurology), F.C.P.S. (Medicine), MRCP (UK), FRCP LONDON
Internal Medicine Specialist
MBBS, MCPS
Bisphosphonates are used as first-line pharmacologictreatment for osteoporosis. In patients who cannot tolerate or whose symptoms do not improve with bisphosphonate therapy, teriparatide (Forteo) and denosumab (Prolia) are effective alternative medications to prevent osteoporotic fractures